Brain drain has always been a topic that has made us sweat and sweat. But the main question is what makes young Indians knock on the doors of overseas employers? When 24-year-old entrepreneur Anagha Rajesh announced that her startup, BioCompute, would be relocating from Bengaluru to San Francisco, it was easy to incriminate the decision as another case of Indian talent going overseas. But Rajesh’s explanation tells a more uncomfortable story. It’s not about a lack of ambition. It’s about where revolutionary ideas find believers. After spending two years building one of India’s most ambitious deep-tech companies, Rajesh has concluded that the ecosystem that helped him reach the starting line is not yet ready to help him cross the finish line.The decision raises a larger question that India has wrestled with for decades: Can the country produce world-changing scientific companies, or will its boldest founders continue to seek validation elsewhere?
Building the future of data storage
The challenge Rajesh chose to tackle was never a conventional startup idea. BioCompute is trying something that sounds like science fiction: storing digital information in DNA.As artificial intelligence, cloud computing and digital services generate unprecedented volumes of data, the world’s storage infrastructure is approaching a scale problem. Data centers consume huge amounts of land, electricity and cooling resources.DNA offers a radically different possibility. Nature has stored information efficiently for billions of years. A small biological structure can contain an amazing amount of data. If scientists can harness that ability, future storage systems could become dramatically smaller, denser, and more energy efficient than today’s hardware. This vision became the foundation of BioCompute.Founded in 2024, the company decided to make the IT infrastructure operate with the efficiency of biological systems. It was a bold goal, especially for a founder in his early twenties.Still, the startup made steady progress. Over two years, Rajesh assembled a specialized team, raised over ₹5 crore from investors including WTF Fund, Grad Capital and 1517 Fund, established lab operations, conducted thousands of experiments and built an end-to-end prototype.By its own account, BioCompute has become the first lab in India to pursue DNA data storage at this scale. For many startups, that would be the success story.For BioCompute, it was just the beginning.
The valley understood the vision
The transition from lab progress to commercial product is often where deep-tech companies face their toughest test.Building prototypes is hard. Building products that customers can actually use is exponentially more difficult. The next phase is precisely where Rajesh believes Silicon Valley offers advantages that India currently lacks.In conversations with Vyom Bhatia on his channel, which revolve around the decisions, one theme came up repeatedly. People in San Francisco focused less on immediate revenue and more on what the company would need to achieve its long-term mission.Rather than asking how quickly the startup could generate revenue, they asked how they could help remove the obstacles that prevent the technology from becoming a reality.For a founder who builds DNA storage chips instead of another software application, that distinction matters. Deep-tech companies often require years of research, large capital commitments and extraordinary patience before producing commercial returns.Traditional startup metrics aren’t always suitable for companies trying to solve frontier scientific problems. Rajesh found an audience willing to think in decades rather than quarters.
India’s deep-tech dilemma
His departure comes at an awkward time for India’s innovation ecosystem. The country has spent years celebrating its emergence as a startup powerhouse. Thousands of businesses were created. Billions of dollars have been invested. Unicorns have become symbols of entrepreneurial success.However, much of this success has been focused on software, consumer internet, fintech and platform businesses. Deep technology remains a different challenge.Scientific ventures require longer lead times, larger research budgets, and investors willing to tolerate uncertainty for extended periods.Rajesh acknowledged that India has already taken steps in that direction, citing growing support for deep-tech initiatives and research-led funding programs.But he is not convinced that the ecosystem is fully prepared for an ambitious product like BioCompute. His assessment touches a sensitive nerve. Many Indian scientists, engineers and researchers working abroad often express a desire to return home. The country does not suffer from a shortage of intellectual capacity.The missing ingredient, critics argue, is sufficient risk capital dedicated to breakthrough technologies. If the talent exists but funding remains cautious, founders building moonshot technologies will naturally gravitate toward ecosystems where investors are more comfortable supporting uncertainty.
The human cost of relocation
Behind every startup relocation announcement lies a more personal story. For Rajesh, moving BioCompute to San Francisco was not just a strategic business decision. It also meant dismantling the Bengaluru operation that helped build the company from the ground up.Some of the most difficult conversations he faced involved members of his team. These were researchers, engineers and builders who had devoted countless hours to experiments, problem solving and development. Together, they pursued a problem that few others in India sought to solve.The emotional weight of those departures was evident in his reflections. Last week, he publicly listed office furniture, lab equipment and chemicals for sale, offering a stark visual reminder that startup transitions aren’t just about budgets and business plans. They involve people, careers and dreams. Every transfer leaves something behind.
A test case for India’s future
BioCompute’s move should not be seen as just the story of a startup leaving India. It’s a test case. If Rajesh succeeds in commercializing DNA data storage from San Francisco, his journey will become part of a larger debate about where frontier innovation is most likely to thrive.For India, the lesson may be uncomfortable but valuable. The country has already shown that it can produce world-class talent. The next challenge is to show that it can also create an environment where the most ambitious scientific companies choose to stay.Because the competition for the future will not be decided by who has the brightest mind. It will be decided by who is willing to bet on them.As BioCompute prepares to build its first DNA storage chips and bring them to customers, Rajesh is embarking on what he describes as an exciting and nerve-wracking new chapter.For his company, the destination is San Francisco. For India, the bigger question remains unanswered: When will the next Anagha Rajesh emerge, will she feel compelled to leave?
